| The high cost of prescription drugs in the United States: origins and prospects for reform AS Kesselheim, J Avorn, A Sarpatwari Jama 316 (8), 858-871, 2016 | 686 | 2016 |
| Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review R Stasi, A Sarpatwari, JB Segal, J Osborn, ML Evangelista, N Cooper, ... Blood, The Journal of the American Society of Hematology 113 (6), 1231-1240, 2009 | 476 | 2009 |
| Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database A Sarpatwari, D Bennett, JW Logie, A Shukla, KJ Beach, AC Newland, ... haematologica 95 (7), 1167, 2010 | 259 | 2010 |
| Practical, legal, and ethical issues in expanded access to investigational drugs JJ Darrow, A Sarpatwari, J Avorn, AS Kesselheim New England Journal of Medicine 372 (3), 279-286, 2015 | 161 | 2015 |
| Autologous 111In‐labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United … A Sarpatwari, D Provan, S Erqou, R Sobnack, FW David Tai, AC Newland British journal of haematology 151 (5), 477-487, 2010 | 98 | 2010 |
| Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims RJ Desai, A Sarpatwari, S Dejene, NF Khan, J Lii, JR Rogers, SK Dutcher, ... PLoS medicine 16 (3), e1002763, 2019 | 94 | 2019 |
| The opioid epidemic: fixing a broken pharmaceutical market A Sarpatwari, MS Sinha, AS Kesselheim Harv. L. & Pol'y Rev. 11, 463, 2017 | 93 | 2017 |
| Why are biosimilars not living up to their promise in the US? MZ Zhai, A Sarpatwari, AS Kesselheim AMA journal of ethics 21 (8), 668-678, 2019 | 69 | 2019 |
| Progress and hurdles for follow-on biologics A Sarpatwari, J Avorn, AS Kesselheim New England Journal of Medicine 372 (25), 2380-2382, 2015 | 66 | 2015 |
| Expressing findings from meta‐analyses of continuous outcomes in terms of risks J Anzures‐Cabrera, A Sarpatwari, JPT Higgins Statistics in medicine 30 (25), 2967-2985, 2011 | 63 | 2011 |
| Competition and price among brand-name drugs in the same class: a systematic review of the evidence A Sarpatwari, J DiBello, M Zakarian, M Najafzadeh, AS Kesselheim PLoS medicine 16 (7), e1002872, 2019 | 60 | 2019 |
| The US biosimilar market: stunted growth and possible reforms A Sarpatwari, R Barenie, G Curfman, JJ Darrow, AS Kesselheim Clinical Pharmacology & Therapeutics 105 (1), 92-100, 2019 | 57 | 2019 |
| Strategies that delay market entry of generic drugs KN Vokinger, AS Kesselheim, J Avorn, A Sarpatwari JAMA internal medicine 177 (11), 1665-1669, 2017 | 55 | 2017 |
| Evaluating the impact of the Orphan Drug Act’s seven-year market exclusivity period A Sarpatwari, RF Beall, A Abdurrob, M He, AS Kesselheim Health Affairs 37 (5), 732-737, 2018 | 51 | 2018 |
| Reforming the Orphan Drug Act for the 21st century A Sarpatwari, AS Kesselheim New England Journal of Medicine 381 (2), 106-108, 2019 | 47 | 2019 |
| Variation in prescription drug prices by retail pharmacy type: a national cross-sectional study J Luo, M Kulldorff, A Sarpatwari, A Pawar, AS Kesselheim Annals of Internal Medicine 171 (9), 605-611, 2019 | 43 | 2019 |
| Lessons from the impact of price regulation on the pricing of anticancer drugs in Germany: study assesses the effects of female political representation on mortality among … VD Lauenroth, AS Kesselheim, A Sarpatwari, AD Stern Health Affairs 39 (7), 1185-1193, 2020 | 38 | 2020 |
| State initiatives to control medication costs—can transparency legislation help? A Sarpatwari, J Avorn, AS Kesselheim New England Journal of Medicine 374 (24), 2301-2304, 2016 | 38 | 2016 |
| Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study RJ Desai, A Sarpatwari, S Dejene, NF Khan, J Lii, JR Rogers, SK Dutcher, ... bmj 361, 2018 | 37 | 2018 |
| US public investment in development of mRNA covid-19 vaccines: retrospective cohort study HS Lalani, S Nagar, A Sarpatwari, RE Barenie, J Avorn, BN Rome, ... bmj 380, 2023 | 35 | 2023 |
Jerry AvornHarvard Medical SchoolAdresse e-mail validée de partners.org
